Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1998 1
1999 1
2000 1
2001 2
2004 1
2005 2
2007 1
2008 5
2009 4
2010 10
2011 17
2012 20
2013 31
2014 110
2015 138
2016 113
2017 129
2018 148
2019 141
2020 160
2021 227
2022 197
2023 159
2024 47

Text availability

Article attribute

Article type

Publication date

Search Results

1,505 results

Results by year

Filters applied: . Clear all
Unknown field was ignored: [Grants and Funding]
Page 1
A replicating RNA vaccine confers protection in a rhesus macaque model of Crimean-Congo hemorrhagic fever.
Hawman DW, Leventhal SS, Meade-White K, Khandhar A, Murray J, Lovaglio J, Shaia C, Saturday G, Hinkley T, Erasmus J, Feldmann H. Hawman DW, et al. NPJ Vaccines. 2024 May 20;9(1):86. doi: 10.1038/s41541-024-00887-z. NPJ Vaccines. 2024. PMID: 38769294
Currently, there are no widely available vaccines, and although the World Health Organization recommends ribavirin for treatment, its efficacy is unclear. ...
Currently, there are no widely available vaccines, and although the World Health Organization recommends ribavirin for treatment, its …
Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendations.
Dartois V, Bonfield TL, Boyce JP, Daley CL, Dick T, Gonzalez-Juarrero M, Gupta S, Kramnik I, Lamichhane G, Laughon BE, Lorè NI, Malcolm KC, Olivier KN, Tuggle KL, Jackson M. Dartois V, et al. Tuberculosis (Edinb). 2024 Mar 19;147:102503. doi: 10.1016/j.tube.2024.102503. Online ahead of print. Tuberculosis (Edinb). 2024. PMID: 38729070 Review.
To address this issue, a series of three workshops were hosted in 2023 by the Cystic Fibrosis Foundation (CFF) and the National Institute of Allergy and Infectious Diseases (NIAID) to review the current murine models of M. a …
To address this issue, a series of three workshops were hosted in 2023 by the Cystic Fibrosis Foundation (CFF) and the National In …
Understanding the biology of monkeypox virus to prevent future outbreaks.
Moss B. Moss B. Nat Microbiol. 2024 May 9. doi: 10.1038/s41564-024-01690-1. Online ahead of print. Nat Microbiol. 2024. PMID: 38724757 Review.
Between January 2022 and October 2023, about 91,000 confirmed cases from 115 countries were reported, leading the World Health Organization to declare a public health emergency. The basic biology of monkeypox virus (MPXV) can be inferred from other poxviruses, such …
Between January 2022 and October 2023, about 91,000 confirmed cases from 115 countries were reported, leading the World Health Organi …
Antigenic cartography using hamster sera identifies SARS-CoV-2 JN.1 evasion seen in human XBB.1.5 booster sera.
Wang W, Bhushan GL, Paz S, Stauft CB, Selvaraj P, Goguet E, Bishop-Lilly KA, Subramanian R, Vassell R, Lusvarghi S, Cong Y, Agan B, Richard SA, Epsi NJ, Fries A, Fung CK, Conte MA, Holbrook MR, Wang TT, Burgess TH, Mitre E, Pollett SD, Katzelnick LC, Weiss CD. Wang W, et al. bioRxiv [Preprint]. 2024 Apr 6:2024.04.05.588359. doi: 10.1101/2024.04.05.588359. bioRxiv. 2024. PMID: 38712124 Free PMC article. Preprint.
Age and gender profiles of HIV infection burden and viraemia: novel metrics for HIV epidemic control in African populations with high antiretroviral therapy coverage.
Brizzi A, Kagaayi J, Ssekubugu R, Abeler-Dörner L, Blenkinsop A, Bonsall D, Chang LW, Fraser C, Galiwango RM, Kigozi G, Kyle I, Monod M, Nakigozi G, Nalugoda F, Rosen JG, Laeyendecker O, Quinn TC, Grabowski MK, Reynolds SJ, Ratmann O; Rakai Health Sciences Program. Brizzi A, et al. medRxiv [Preprint]. 2024 Apr 22:2024.04.21.24306145. doi: 10.1101/2024.04.21.24306145. medRxiv. 2024. PMID: 38712115 Free PMC article. Preprint.
Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaques.
Kaiser JA, Nelson CE, Liu X, Park HS, Matsuoka Y, Luongo C, Santos C, Ahlers LRH, Herbert R, Moore IN, Wilder-Kofie T, Moore R, Walker A, Yang L, Munir S, Teng IT, Kwong PD, Dowdell K, Nguyen H, Kim J, Cohen JI, Johnson RF, Garza NL, Via LE, Barber DL, Buchholz UJ, Le Nouën C. Kaiser JA, et al. Nat Commun. 2024 Apr 26;15(1):3553. doi: 10.1038/s41467-024-47784-6. Nat Commun. 2024. PMID: 38670948 Free PMC article.
Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria.
Kayentao K, Ongoiba A, Preston AC, Healy SA, Hu Z, Skinner J, Doumbo S, Wang J, Cisse H, Doumtabe D, Traore A, Traore H, Djiguiba A, Li S, Peterson ME, Telscher S, Idris AH, Adams WC, McDermott AB, Narpala S, Lin BC, Serebryannyy L, Hickman SP, McDougal AJ, Vazquez S, Reiber M, Stein JA, Gall JG, Carlton K, Schwabl P, Traore S, Keita M, Zéguimé A, Ouattara A, Doucoure M, Dolo A, Murphy SC, Neafsey DE, Portugal S, Djimdé A, Traore B, Seder RA, Crompton PD; Mali Malaria mAb Trial Team. Kayentao K, et al. N Engl J Med. 2024 May 2;390(17):1549-1559. doi: 10.1056/NEJMoa2312775. Epub 2024 Apr 26. N Engl J Med. 2024. PMID: 38669354 Clinical Trial.
CONCLUSIONS: Subcutaneous administration of L9LS to children was protective against P. falciparum infection and clinical malaria over a period of 6 months. (Funded by the National Institute of Allergy and Infectious Diseases; Clini …
CONCLUSIONS: Subcutaneous administration of L9LS to children was protective against P. falciparum infection and clinical malaria over a peri …
1,505 results